KRYS KRYSTAL BIOTECH INC More: the full row for KRYSTAL BIOTECH INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 358,379 shares; 2025Q1: 441,758 shares; 2025Q2: 922,958 shares; 2025Q3: 1,018,831 shares; 2025Q4: 941,059 shares; 2026Q1: 1,153,087 shares; 2026Q2: 939,254 shares; 2026Q3: 1,139,700 shares 1,139,700 $379M 13.47% +200,446 Timeline PODD INSULET CORP More: the full row for INSULET CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 150,000 shares; 2026Q1: 562,500 shares; 2026Q2: 1,049,000 shares; 2026Q3: 1,726,500 shares 1,726,500 $225M 8.01% +677,500 Timeline NVCR NOVOCURE LTD More: the full row for NOVOCURE LTD Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,739,704 shares; 2025Q1: 5,521,414 shares; 2025Q2: 6,904,302 shares; 2025Q3: 9,644,872 shares; 2025Q4: 8,530,665 shares; 2026Q1: 10,492,391 shares; 2026Q2: 9,913,401 shares; 2026Q3: 9,425,776 shares 9,425,776 $150M 5.34% -487,625 Timeline TGTX TG THERAPEUTICS INC More: the full row for TG THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,681,242 shares; 2025Q1: 2,846,703 shares; 2025Q2: 2,243,935 shares; 2025Q3: 3,844,731 shares; 2025Q4: 3,139,312 shares; 2026Q1: 4,029,319 shares; 2026Q2: 2,927,895 shares; 2026Q3: 2,556,168 shares 2,556,168 $143M 5.07% -371,727 Timeline UTHR UNITED THERAPEUTICS CORP DEL More: the full row for UNITED THERAPEUTICS CORP DEL Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 109,394 shares; 2025Q1: 155,394 shares; 2025Q2: 209,794 shares; 2025Q3: 150,000 shares; 2025Q4: 60,000 shares; 2026Q1: 187,187 shares; 2026Q2: 225,587 shares; 2026Q3: 259,000 shares 259,000 $140M 4.99% +33,413 Timeline CELC CELCUITY INC More: the full row for CELCUITY INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,565,087 shares; 2025Q1: 2,574,122 shares; 2025Q2: 3,011,818 shares; 2025Q3: 1,178,860 shares; 2025Q4: 1,808,258 shares; 2026Q1: 1,284,378 shares; 2026Q2: 1,704,318 shares; 2026Q3: 1,682,760 shares 1,682,760 $134M 4.76% -21,558 Timeline RIGL RIGEL PHARMACEUTICALS INC More: the full row for RIGEL PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,130,679 shares; 2025Q1: 1,130,679 shares; 2025Q2: 658,145 shares; 2025Q3: 330,010 shares; 2025Q4: 300,034 shares; 2026Q1: 10,000 shares; 2026Q2: 1,843,504 shares; 2026Q3: 1,843,504 shares 1,843,504 $88.8M 3.16% 0 Timeline INSP INSPIRE MED SYS INC More: the full row for INSPIRE MED SYS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 39,000 shares; 2025Q2: 109,000 shares; 2025Q3: 728,188 shares; 2025Q4: 299,399 shares; 2026Q1: 576,299 shares; 2026Q2: 1,931,436 shares; 2026Q3: 1,206,828 shares 1,206,828 $83.7M 2.98% -724,608 Timeline ERAS ERASCA INC More: the full row for ERASCA INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,162,162 shares; 2025Q1: 2,162,162 shares; 2025Q2: 2,162,162 shares; 2025Q3: 2,162,162 shares; 2025Q4: 2,162,162 shares; 2026Q1: not reported; 2026Q2: 2,700,000 shares; 2026Q3: 5,112,000 shares 5,112,000 $74.9M 2.66% +2,412,000 Timeline BBNX BETA BIONICS INC More: the full row for BETA BIONICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 3,395,341 shares; 2025Q2: 3,820,158 shares; 2025Q3: 3,870,158 shares; 2025Q4: 2,534,565 shares; 2026Q1: 4,354,501 shares; 2026Q2: 4,393,714 shares; 2026Q3: 3,743,714 shares 3,743,714 $71.1M 2.53% -650,000 Timeline ANIP ANI PHARMACEUTICALS INC More: the full row for ANI PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 205,294 shares; 2025Q1: 224,684 shares; 2025Q2: 50,743 shares; 2025Q3: 340,243 shares; 2025Q4: 486,243 shares; 2026Q1: 820,243 shares; 2026Q2: 867,760 shares; 2026Q3: 975,500 shares 975,500 $70.9M 2.52% +107,740 Timeline VCEL VERICEL CORP More: the full row for VERICEL CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 80,696 shares; 2025Q1: not reported; 2025Q2: 50,953 shares; 2025Q3: 497,953 shares; 2025Q4: 764,000 shares; 2026Q1: 2,549,079 shares; 2026Q2: 1,459,152 shares; 2026Q3: 1,554,059 shares 1,554,059 $62.4M 2.22% +94,907 Timeline GERN GERON CORP More: the full row for GERON CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 2,400,000 shares; 2025Q2: 16,140,000 shares; 2025Q3: 17,290,000 shares; 2025Q4: 23,290,000 shares; 2026Q1: 41,508,659 shares; 2026Q2: 42,808,659 shares; 2026Q3: 46,768,659 shares 46,768,659 $57.5M 2.04% +3,960,000 Timeline PBLS PARABILIS MEDICINES INC More: the full row for PARABILIS MEDICINES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 1,465,070 shares; 2026Q3: 1,684,512 shares 1,684,512 $54.4M 1.93% +219,442 Timeline ARGX ARGENX SE More: the full row for ARGENX SE Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 28,940 shares; 2025Q2: 42,876 shares; 2025Q3: 69,426 shares; 2025Q4: 31,726 shares; 2026Q1: 3,500 shares; 2026Q2: 19,955 shares; 2026Q3: 49,350 shares 49,350 $47.3M 1.68% +29,395 Timeline AXGN AXOGEN INC More: the full row for AXOGEN INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,955,943 shares; 2025Q1: 1,446,117 shares; 2025Q2: 1,459,395 shares; 2025Q3: 1,726,553 shares; 2025Q4: 1,206,855 shares; 2026Q1: 679,170 shares; 2026Q2: 57,036 shares; 2026Q3: 1,081,000 shares 1,081,000 $45.3M 1.61% +1,023,964 Timeline NPCE NEUROPACE INC More: the full row for NEUROPACE INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,433,168 shares; 2025Q1: 2,608,168 shares; 2025Q2: 2,312,957 shares; 2025Q3: 2,957,957 shares; 2025Q4: 2,703,208 shares; 2026Q1: 2,932,207 shares; 2026Q2: 2,911,122 shares; 2026Q3: 3,218,000 shares 3,218,000 $44.3M 1.57% +306,878 Timeline EOLS EVOLUS INC More: the full row for EVOLUS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 697,158 shares; 2025Q1: 1,079,158 shares; 2025Q2: 2,119,000 shares; 2025Q3: 1,450,000 shares; 2025Q4: 1,070,000 shares; 2026Q1: 2,245,360 shares; 2026Q2: 822,428 shares; 2026Q3: 5,090,000 shares 5,090,000 $40.7M 1.45% +4,267,572 Timeline ZLAB ZAI LAB LTD More: the full row for ZAI LAB LTD Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 1,543,000 shares 1,543,000 $40.6M 1.44% new Timeline PGNY PROGYNY INC More: the full row for PROGYNY INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 2,067,000 shares; 2026Q2: 1,602,000 shares; 2026Q3: 1,582,000 shares 1,582,000 $39.9M 1.42% -20,000 Timeline TRVI TREVI THERAPEUTICS INC More: the full row for TREVI THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 700,000 shares; 2025Q3: 25,000 shares; 2025Q4: 900,000 shares; 2026Q1: 1,620,000 shares; 2026Q2: 1,179,618 shares; 2026Q3: 2,727,727 shares 2,727,727 $39.1M 1.39% +1,548,109 Timeline NVCT NUVECTIS PHARMA INC More: the full row for NUVECTIS PHARMA INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 1,000,000 shares; 2026Q3: 1,710,658 shares 1,710,658 $36.1M 1.28% +710,658 Timeline FOCL EDAP TMS S A More: the full row for EDAP TMS S A Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 7,309,254 shares; 2025Q1: 7,309,254 shares; 2025Q2: 7,309,254 shares; 2025Q3: 7,309,254 shares; 2025Q4: 7,309,254 shares; 2026Q1: 7,309,254 shares; 2026Q2: 7,309,254 shares; 2026Q3: 7,309,254 shares 7,309,254 $32.7M 1.16% 0 Timeline AVLN AVALYN PHARMACEUTICALS INC More: the full row for AVALYN PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 419,000 shares; 2026Q3: 1,019,000 shares 1,019,000 $29M 1.03% +600,000 Timeline KOD KODIAK SCIENCES INC More: the full row for KODIAK SCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 19,644 shares; 2025Q4: 60,000 shares; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 286,966 shares 286,966 $27.2M 0.97% new Timeline SLN SILENCE THERAPEUTICS PLC More: the full row for SILENCE THERAPEUTICS PLC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 630,000 shares; 2026Q3: 2,385,700 shares 2,385,700 $26.1M 0.93% +1,755,700 Timeline IKT INHIBIKASE THERAPEUTICS INC More: the full row for INHIBIKASE THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 6,325,000 shares; 2025Q1: 6,325,000 shares; 2025Q2: 6,325,000 shares; 2025Q3: 6,325,000 shares; 2025Q4: 10,875,000 shares; 2026Q1: 10,875,000 shares; 2026Q2: 10,875,000 shares; 2026Q3: 11,225,000 shares 11,225,000 $23.1M 0.82% +350,000 Timeline RCUS ARCUS BIOSCIENCES INC More: the full row for ARCUS BIOSCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 711,983 shares; 2026Q1: 451,983 shares; 2026Q2: 1,168,738 shares; 2026Q3: 862,000 shares 862,000 $22.3M 0.79% -306,738 Timeline LEGN LEGEND BIOTECH CORP More: the full row for LEGEND BIOTECH CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 1,205,000 shares; 2026Q3: 1,085,550 shares 1,085,550 $21.6M 0.77% -119,450 Timeline NRIX NURIX THERAPEUTICS INC More: the full row for NURIX THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,102,833 shares; 2025Q1: 2,422,833 shares; 2025Q2: 2,422,833 shares; 2025Q3: 2,422,833 shares; 2025Q4: 1,219,394 shares; 2026Q1: 938,163 shares; 2026Q2: 1,465,163 shares; 2026Q3: 892,163 shares 892,163 $21.2M 0.75% -573,000 Timeline INBX INHIBRX BIOSCIENCES INC More: the full row for INHIBRX BIOSCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 25,000 shares; 2026Q1: 131,000 shares; 2026Q2: not reported; 2026Q3: 210,000 shares 210,000 $21M 0.75% new Timeline ANL ADLAI NORTYE GROUP LTD More: the full row for ADLAI NORTYE GROUP LTD Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 405,523 shares; 2026Q3: 1,272,355 shares 1,272,355 $20.4M 0.72% +866,832 Timeline PALI PALISADE BIO INC More: the full row for PALISADE BIO INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 13,063,687 shares; 2026Q3: 14,996,154 shares 14,996,154 $20.2M 0.72% +1,932,467 Timeline ALKS ALKERMES PLC More: the full row for ALKERMES PLC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,322,364 shares; 2026Q1: 1,970,864 shares; 2026Q2: 1,029,252 shares; 2026Q3: 497,706 shares 497,706 $20.2M 0.72% -531,546 Timeline TNGX TANGO THERAPEUTICS INC More: the full row for TANGO THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 730,000 shares; 2025Q3: 300,000 shares; 2025Q4: 10,000 shares; 2026Q1: 450,000 shares; 2026Q2: 709,000 shares; 2026Q3: 802,297 shares 802,297 $20M 0.71% +93,297 Timeline BDSX BIODESIX INC More: the full row for BIODESIX INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 416,599 shares; 2026Q2: 585,958 shares; 2026Q3: 667,835 shares 667,835 $19.9M 0.71% +81,877 Timeline PHVS PHARVARIS N V More: the full row for PHARVARIS N V Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 814,652 shares; 2025Q1: 814,652 shares; 2025Q2: 732,968 shares; 2025Q3: 647,052 shares; 2025Q4: 702,052 shares; 2026Q1: 702,052 shares; 2026Q2: 730,907 shares; 2026Q3: 604,000 shares 604,000 $19.2M 0.68% -126,907 Timeline INSM INSMED INC More: the full row for INSMED INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 320,272 shares; 2025Q1: 274,272 shares; 2025Q2: 72,772 shares; 2025Q3: 2,550 shares; 2025Q4: 48,500 shares; 2026Q1: 10,250 shares; 2026Q2: 90,250 shares; 2026Q3: 147,000 shares 147,000 $16.8M 0.6% +56,750 Timeline PRAX PRAXIS PRECISION MEDICINES I More: the full row for PRAXIS PRECISION MEDICINES I Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 243,540 shares; 2025Q1: 1,139,740 shares; 2025Q2: 966,740 shares; 2025Q3: 859,166 shares; 2025Q4: 362,966 shares; 2026Q1: 330,517 shares; 2026Q2: 177,517 shares; 2026Q3: 56,515 shares 56,515 $16.5M 0.59% -121,002 Timeline JBIO JADE BIOSCIENCES INC More: the full row for JADE BIOSCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 796,744 shares; 2025Q3: 796,744 shares; 2025Q4: 796,744 shares; 2026Q1: 796,744 shares; 2026Q2: 1,550,690 shares; 2026Q3: 1,170,928 shares 1,170,928 $16.5M 0.58% -379,762 Timeline KNSA KINIKSA PHARMACEUTICALS INTL More: the full row for KINIKSA PHARMACEUTICALS INTL Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 469,500 shares; 2025Q2: 254,689 shares; 2025Q3: 150,000 shares; 2025Q4: 587,000 shares; 2026Q1: 521,353 shares; 2026Q2: 246,353 shares; 2026Q3: 218,958 shares 218,958 $16.3M 0.58% -27,395 Timeline CNMD CONMED CORP More: the full row for CONMED CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 347,333 shares 347,333 $16.1M 0.57% new Timeline ETON ETON PHARMACEUTICALS INC More: the full row for ETON PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 285,000 shares; 2025Q3: 200,000 shares; 2025Q4: not reported; 2026Q1: 166,381 shares; 2026Q2: not reported; 2026Q3: 308,101 shares 308,101 $15.9M 0.56% new Timeline KIDS ORTHOPEDIATRICS CORP More: the full row for ORTHOPEDIATRICS CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 45,000 shares; 2025Q2: 45,000 shares; 2025Q3: 128,000 shares; 2025Q4: 525,447 shares; 2026Q1: 615,447 shares; 2026Q2: 732,144 shares; 2026Q3: 710,198 shares 710,198 $15.8M 0.56% -21,946 Timeline ORGO ORGANOGENESIS HLDGS INC More: the full row for ORGANOGENESIS HLDGS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 12,484,876 shares; 2025Q1: 12,478,351 shares; 2025Q2: 12,343,351 shares; 2025Q3: 12,131,699 shares; 2025Q4: 9,985,951 shares; 2026Q1: 10,085,951 shares; 2026Q2: 10,140,951 shares; 2026Q3: 11,300,951 shares 11,300,951 $15.5M 0.55% +1,160,000 Timeline GRAL GRAIL INC More: the full row for GRAIL INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 11,000 shares; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 108,500 shares 108,500 $15.2M 0.54% new Timeline MBX MBX BIOSCIENCES INC More: the full row for MBX BIOSCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 275,000 shares; 2025Q4: 408,900 shares; 2026Q1: 178,897 shares; 2026Q2: 515,279 shares; 2026Q3: 258,897 shares 258,897 $15.2M 0.54% -256,382 Timeline EWTX EDGEWISE THERAPEUTICS INC More: the full row for EDGEWISE THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 183,300 shares; 2025Q1: 72,300 shares; 2025Q2: 76,493 shares; 2025Q3: not reported; 2025Q4: 910,000 shares; 2026Q1: 1,449,915 shares; 2026Q2: 450,889 shares; 2026Q3: 329,987 shares 329,987 $13.4M 0.48% -120,902 Timeline AMRX AMNEAL PHARMACEUTICALS INC More: the full row for AMNEAL PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 658,000 shares 658,000 $13.3M 0.47% new Timeline PRLD PRELUDE THERAPEUTICS INC More: the full row for PRELUDE THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 3,378,378 shares; 2026Q3: 3,378,378 shares 3,378,378 $13.2M 0.47% 0 Timeline SEPN SEPTERNA INC More: the full row for SEPTERNA INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 675,409 shares; 2025Q1: 751,353 shares; 2025Q2: 75,456 shares; 2025Q3: 18,260 shares; 2025Q4: 383,368 shares; 2026Q1: 275,000 shares; 2026Q2: 275,000 shares; 2026Q3: 330,000 shares 330,000 $12.9M 0.46% +55,000 Timeline SNDX SYNDAX PHARMACEUTICALS INC More: the full row for SYNDAX PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,492,000 shares; 2025Q1: 816,610 shares; 2025Q2: 1,092,110 shares; 2025Q3: 2,012,110 shares; 2025Q4: 2,247,110 shares; 2026Q1: 1,726,908 shares; 2026Q2: 1,628,039 shares; 2026Q3: 615,990 shares 615,990 $11.6M 0.41% -1,012,049 Timeline SNY SANOFI SA More: the full row for SANOFI SA Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 226,218 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 275,000 shares 275,000 $11.3M 0.4% new Timeline CCCC C4 THERAPEUTICS INC More: the full row for C4 THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 6,978,942 shares; 2025Q1: 6,978,942 shares; 2025Q2: 6,978,942 shares; 2025Q3: 7,053,942 shares; 2025Q4: 3,803,942 shares; 2026Q1: 3,803,942 shares; 2026Q2: 3,377,981 shares; 2026Q3: 3,357,981 shares 3,357,981 $11.2M 0.4% -20,000 Timeline PRCT PROCEPT BIOROBOTICS CORP More: the full row for PROCEPT BIOROBOTICS CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 160,000 shares; 2026Q2: 1,003,000 shares; 2026Q3: 600,358 shares 600,358 $10.9M 0.39% -402,642 Timeline TYRA TYRA BIOSCIENCES INC More: the full row for TYRA BIOSCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 125,000 shares; 2026Q1: 10,000 shares; 2026Q2: not reported; 2026Q3: 445,025 shares 445,025 $9.73M 0.35% new Timeline YARW YARROW BIOSCIENCE INC More: the full row for YARROW BIOSCIENCE INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 416,993 shares 416,993 $9.39M 0.33% new Timeline URGN UROGEN PHARMA LTD More: the full row for UROGEN PHARMA LTD Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 2,185,000 shares; 2025Q3: 679,000 shares; 2025Q4: 150,000 shares; 2026Q1: 727,000 shares; 2026Q2: 829,810 shares; 2026Q3: 230,274 shares 230,274 $9.36M 0.33% -599,536 Timeline TWST TWIST BIOSCIENCE CORP More: the full row for TWIST BIOSCIENCE CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 354,401 shares; 2025Q3: 1,866,234 shares; 2025Q4: 1,861,802 shares; 2026Q1: 1,226,629 shares; 2026Q2: 104,629 shares; 2026Q3: 47,532 shares 47,532 $9.19M 0.33% -57,097 Timeline AZN ASTRAZENECA PLC More: the full row for ASTRAZENECA PLC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 52,500 shares 52,500 $8.48M 0.3% new Timeline IOVA IOVANCE BIOTHERAPEUTICS INC More: the full row for IOVANCE BIOTHERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 6,560,000 shares; 2025Q1: 7,785,000 shares; 2025Q2: 3,261,707 shares; 2025Q3: 976,707 shares; 2025Q4: not reported; 2026Q1: 1,000,000 shares; 2026Q2: 150,000 shares; 2026Q3: 551,977 shares 551,977 $8.18M 0.29% +401,977 Timeline XENE XENON PHARMACEUTICALS INC More: the full row for XENON PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 78,800 shares; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 292,000 shares; 2026Q2: 267,000 shares; 2026Q3: 205,000 shares 205,000 $7.62M 0.27% -62,000 Timeline RVMD REVOLUTION MEDICINES INC More: the full row for REVOLUTION MEDICINES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 201,084 shares; 2025Q1: 84,784 shares; 2025Q2: 10,000 shares; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 36,249 shares 36,249 $7.44M 0.26% new Timeline BMRN BIOMARIN PHARMACEUTICAL INC More: the full row for BIOMARIN PHARMACEUTICAL INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,001,400 shares; 2025Q1: 1,079,304 shares; 2025Q2: 902,304 shares; 2025Q3: 890,304 shares; 2025Q4: 1,320,000 shares; 2026Q1: 650,572 shares; 2026Q2: 375,572 shares; 2026Q3: 121,120 shares 121,120 $7.27M 0.26% -254,452 Timeline CAPR CAPRICOR THERAPEUTICS INC More: the full row for CAPRICOR THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 646,390 shares; 2026Q1: not reported; 2026Q2: 761,737 shares; 2026Q3: 699,149 shares 699,149 $6.62M 0.24% -62,588 Timeline IVVD INVIVYD INC More: the full row for INVIVYD INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 7,708,727 shares; 2026Q1: 7,708,727 shares; 2026Q2: 7,708,727 shares; 2026Q3: 7,524,958 shares 7,524,958 $6.55M 0.23% -183,769 Timeline LUNG PULMONX CORP More: the full row for PULMONX CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 2,038,323 shares; 2026Q1: 2,788,323 shares; 2026Q2: 2,788,323 shares; 2026Q3: 3,088,323 shares 3,088,323 $5.9M 0.21% +300,000 Timeline AVTX AVALO THERAPEUTICS INC More: the full row for AVALO THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 441,978 shares; 2026Q1: 441,978 shares; 2026Q2: 1,654,978 shares; 2026Q3: 383,594 shares 383,594 $5.88M 0.21% -1,271,384 Timeline CSTL CASTLE BIOSCIENCES INC More: the full row for CASTLE BIOSCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 252,917 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 141,137 shares 141,137 $5.01M 0.18% new Timeline TRAX FIRST TRACKS BIOTHERAPEUTICS More: the full row for FIRST TRACKS BIOTHERAPEUTICS Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 140,500 shares 140,500 $4.98M 0.18% new Timeline GKOS GLAUKOS CORP More: the full row for GLAUKOS CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 25,552 shares 25,552 $4.2M 0.15% new Timeline TCGX TCGX ACQUISITION CORP More: the full row for TCGX ACQUISITION CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 225,000 shares 225,000 $2.81M 0.1% new Timeline ETRA ELECTRA THERAPEUTICS INC More: the full row for ELECTRA THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 250,000 shares 250,000 $2.81M 0.1% new Timeline MSLE SATELLOS BIOSCIENCE INC More: the full row for SATELLOS BIOSCIENCE INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 414,359 shares; 2026Q2: 314,359 shares; 2026Q3: 330,102 shares 330,102 $2.81M 0.1% +15,743 Timeline SLDB SOLID BIOSCIENCES INC More: the full row for SOLID BIOSCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 150,000 shares; 2026Q3: 368,123 shares 368,123 $2.66M 0.09% +218,123 Timeline SABS SAB BIOTHERAPEUTICS INC More: the full row for SAB BIOTHERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 1,050,000 shares; 2026Q2: 900,000 shares; 2026Q3: 672,039 shares 672,039 $2.13M 0.08% -227,961 Timeline CNTX CONTEXT THERAPEUTICS INC More: the full row for CONTEXT THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 6,963,141 shares; 2026Q2: 7,063,141 shares; 2026Q3: 7,063,141 shares 7,063,141 $2.12M 0.08% 0 Timeline ZNTL ZENTALIS PHARMACEUTICALS INC More: the full row for ZENTALIS PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 950,000 shares; 2026Q3: 706,280 shares 706,280 $1.96M 0.07% -243,720 Timeline TNDM TANDEM DIABETES CARE INC More: the full row for TANDEM DIABETES CARE INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 496,039 shares; 2025Q2: 200,000 shares; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 783,000 shares; 2026Q2: 575,000 shares; 2026Q3: 100,000 shares 100,000 $1.63M 0.06% -475,000 Timeline WAY WAYSTAR HLDG CORP More: the full row for WAYSTAR HLDG CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 50,000 shares 50,000 $1.27M 0.05% new Timeline MNKD MANNKIND CORP More: the full row for MANNKIND CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 300,000 shares; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 300,100 shares 300,100 $1.17M 0.04% new Timeline CERS CERUS CORP More: the full row for CERUS CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 4,000,000 shares; 2026Q1: 10,753,700 shares; 2026Q2: 2,500,000 shares; 2026Q3: 450,000 shares 450,000 $1.07M 0.04% -2,050,000 Timeline QGEN QIAGEN NV More: the full row for QIAGEN NV Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 20,000 shares 20,000 $875K 0.03% new Timeline APRE APREA THERAPEUTICS INC More: the full row for APREA THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 1,000,000 shares 1,000,000 $750K 0.03% new Timeline NSPR INSPIREMD INC More: the full row for INSPIREMD INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,378,128 shares; 2025Q1: 945,376 shares; 2025Q2: 1,886,207 shares; 2025Q3: 1,470,934 shares; 2025Q4: 1,150,000 shares; 2026Q1: 1,045,708 shares; 2026Q2: 1,045,708 shares; 2026Q3: 1,045,708 shares 1,045,708 $698K 0.02% 0 Timeline NXTC NEXTCURE INC More: the full row for NEXTCURE INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 90,000 shares 90,000 $451K 0.02% new Timeline INDV INDIVIOR PHARMACEUTICALS INC More: the full row for INDIVIOR PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 1,274,000 shares; 2026Q2: 1,064,000 shares; 2026Q3: 10,000 shares 10,000 $358K 0.01% -1,054,000 Timeline PCSA PROCESSA PHARMACEUTICALS INC More: the full row for PROCESSA PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 160,943 shares 160,943 $264K 0.01% new Timeline BLTE BELITE BIO INC More: the full row for BELITE BIO INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 210,000 shares; 2025Q4: 40,354 shares; 2026Q1: not reported; 2026Q2: 50,524 shares; 2026Q3: 1,524 shares 1,524 $259K 0.01% -49,000 Timeline BNTX BIONTECH SE More: the full row for BIONTECH SE Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 2,500 shares 2,500 $246K 0.01% new Timeline UNH UNITEDHEALTH GROUP INC More: the full row for UNITEDHEALTH GROUP INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 86,250 shares; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 80,000 shares; 2026Q3: 660 shares 660 $242K 0.01% -79,340 Timeline VIR VIR BIOTECHNOLOGY INC More: the full row for VIR BIOTECHNOLOGY INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 2,002,000 shares; 2026Q2: 1,000,000 shares; 2026Q3: 20,971 shares 20,971 $234K 0.01% -979,029 Timeline QDEL QUIDELORTHO CORP More: the full row for QUIDELORTHO CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 547,082 shares; 2025Q1: not reported; 2025Q2: 174,000 shares; 2025Q3: 375,000 shares; 2025Q4: 75,000 shares; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 20,000 shares 20,000 $211K 0.01% new Timeline ATTO ATTOVIA THERAPEUTICS INC More: the full row for ATTOVIA THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 10,000 shares 10,000 $171K 0.01% new Timeline EQ EQUILLIUM INC More: the full row for EQUILLIUM INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 90,000 shares; 2026Q3: 90,000 shares 90,000 $146K 0.01% 0 Timeline RXST RXSIGHT INC More: the full row for RXSIGHT INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 20,000 shares 20,000 $98K <0.01% new Timeline SOPH SOPHIA GENETICS SA More: the full row for SOPHIA GENETICS SA Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 1,850,000 shares; 2026Q2: 1,565,000 shares; 2026Q3: 10,000 shares 10,000 $83.8K <0.01% -1,555,000 Timeline